Outlook Therapeutics Inc OTLK:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:42 PM EDT
7.01quote price arrow down-0.42 (-5.65%)
Volume
89,529
Close
7.43quote price arrow up+0.03 (+0.41%)
Volume
223,109
52 week range
4.00 - 40.60
Loading...
  • Open7.46
  • Day High7.57
  • Day Low7.34
  • Prev Close7.40
  • 52 Week High40.60
  • 52 Week High Date06/06/23
  • 52 Week Low4.00
  • 52 Week Low Date09/08/23

Key Stats

  • Market Cap173.108M
  • Shares Out23.30M
  • 10 Day Average Volume0.26M
  • Dividend-
  • Dividend Yield-
  • Beta0.66
  • YTD % Change-5.71

KEY STATS

  • Open7.46
  • Day High7.57
  • Day Low7.34
  • Prev Close7.40
  • 52 Week High40.60
  • 52 Week High Date06/06/23
  • 52 Week Low4.00
  • 52 Week Low Date09/08/23
  • Market Cap173.108M
  • Shares Out23.30M
  • 10 Day Average Volume0.26M
  • Dividend-
  • Dividend Yield-
  • Beta0.66
  • YTD % Change-5.71

RATIOS/PROFITABILITY

  • EPS (TTM)-3.99
  • P/E (TTM)-1.86
  • Fwd P/E (NTM)-2.19
  • EBITDA (TTM)-47.70M
  • ROE (TTM)-827.71%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-605.00%
  • Debt To Equity (MRQ)-150.12%

EVENTS

  • Earnings Date05/16/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Outlook Therapeutics Inc

 

Profile

MORE
Outlook Therapeutics, Inc. is a biopharmaceutical company. The Company focuses on developing and commercializing ONS-5010 (LYTENAVA (bevacizumab-vikg)), an ophthalmic formulation of bevacizumab for use in retinal indications. The Company's product candidate, ONS-5010, is developed to be administered as an intravitreal injection for the treatment of wet age-related macular degeneration (wet AMD), diabetic macular edema (DME), and branch retinal vein occlusion (BRVO)....
Ralph Thurman
Independent Executive Chairman of the Board
C. Russell Trenary III
President, Chief Executive Officer, Director
Lawrence Kenyon
Chief Financial Officer, Executive Vice President, Treasurer, Company Secretary, Director
Address
111 S. Wood Avenue, Unit #100
Iselin, NJ
08830
United States

Top Peers

SYMBOLLASTCHG%CHG
GNLX
Genelux Corp
3.64+0.06+1.68%
PMVP
PMV Pharmaceuticals Inc
2.16+0.02+0.93%
ALLK
Allakos Inc
1.19UNCHUNCH
LPTX
Leap Therapeutics Inc
2.80+0.05+1.82%
ELTX
Elicio Therapeutics Inc
10.40+0.10+0.97%